| Lesly Pompy, MD | |
|
730 N Macomb St, Suite 410, Monroe, MI 48162-2900 | |
| (734) 242-9482 | |
| (734) 242-6503 |
| Full Name | Lesly Pompy |
|---|---|
| Gender | Male |
| Speciality | Pain Medicine - Interventional Pain Medicine |
| Location | 730 N Macomb St, Monroe, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174578801 | NPI | - | NPPES |
| 2371008 | Medicaid | OH | |
| 4470749 | Other | AETNA | |
| 2826592-10 | Medicaid | MI | |
| 4464106-10 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 4301058720 (Michigan) | Secondary |
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 4301058720 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lesly Pompy, MD 730 N Macomb St, Suite 410, Monroe, MI 48162-2900 Ph: (734) 242-9482 | Lesly Pompy, MD 730 N Macomb St, Suite 410, Monroe, MI 48162-2900 Ph: (734) 242-9482 |
News Archive
Two studies from The Cancer Genome Atlas program reveal details about the genomic landscapes of acute myeloid leukemia and endometrial cancer.
Osiris Therapeutics, Inc., the leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular and orthopedic areas, announced today its financial results for the third quarter of 2009.
Cancer researchers at the University of Calgary are investigating a new tool to use for the prognosis of breast cancer in patients. This new digital tool will help give patients a more accurate assessment of how abnormal and aggressive their cancer is and help doctors recommend the best treatment options.
Chronic disease accounts for 7 of every 10 deaths in the United States and more than 75% of total health care costs. Among people 65 years old and older, over 92% suffer from one or more chronic diseases.
› Verified 1 days ago